Healthcare · Nov 18, 2026
Exergames for Older Adults: A Scoping Review of Adapted Physical Activity Interventions and Health Outcomes
By Patsi C, Yfantidou G, Tsartsapakis I et al.
Background/Objectives: Population aging highlights the need for accessible adapted physical activity (APA) interventions to preserve functional capacity in older adults. Combining exercise with interactive gaming, exergames offer multi-domain benefits. This scoping review mapped primary empirical trials and secondary evidence syntheses on exergame-based APA for older adults. Methods: Guided by Arksey and O’Malley’s framework and PRISMA-ScR guidelines, systematic searches were conducted across PubMed, Scopus, and Web of Science (2013–2026). Data were mapped from 15 independent sources: 10 primary trial cohorts (11 publications; RCTs, crossover, pilot, feasibility studies) and 5 secondary syntheses (4 systematic reviews, 1 overview/meta-analysis). In accordance with scoping review methodology, no formal risk-of-bias assessment was performed. Results: In primary studies, sample sizes ranged from 10 to 319 participants, with nine of ten trial cohorts enrolling fewer than 40 participants (N = 10–39); interventions were brief (2–12 weeks) and cohorts predominantly female. Included studies reported improvements in surrogate fall-risk measures, including static and dynamic balance, mobility, and lower limb strength. Dual-task exergames showed potential for enhancing executive function and positive affect. Customizing game parameters (speed and difficulty) and managing baseline anxiety emerged as key compliance drivers. Direct fall incidence and cost-effectiveness were not evaluated in the primary evidence. Conclusions: Exergame-based APA is a feasible, engaging modality for improving balance surrogates and mobility in older adults. However, evidence is constrained by sample heterogeneity and small pilot designs. Adequately powered randomized controlled trials with standardized dosing protocols and longitudinal follow-up are required to establish clinical efficacy.